Fairvalue-Calculator Fairvalue-Calculator
EN DE

Formosa Optical Technology Co (5312) Fair Value & Analysis

Healthcare · TW · Market cap 5.8B TWD

Price96.90 TWD
Fair Value128.75 TWD
Upside+32.9%
Quality95/100
Evidence: High Range 86.26 TWD – 171.24 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Formosa Optical Technology Co (5312) currently trades at 96.90 TWD, while our model-based Fair Value estimate is 128.75 TWD — implying the stock looks roughly 32.9% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Formosa Optical Technology Co.,Ltd. provides eyecare products in Taiwan. The company provides optical glasses, frames, sunglasses, contact transparent lenses, and color contact lenses. It also offers eye drops and optometry equipment. The company was founded in 1976 and is based in New Taipei City, Taiwan.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Formosa Optical Technology Co (5312) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 128.75 TWD versus a price of 96.90 TWD — about +33% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 5312?
Our 21-model fair value for Formosa Optical Technology Co is 128.75 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 96.90 TWD.
What is the quality score of 5312?
Formosa Optical Technology Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.